The CLSI M45 document, titled "Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria," provides critical guidelines for testing organisms that fall outside the more common species covered in the CLSI M100 standard. Key Features of CLSI M45
Standardized Methodology: It describes broth microdilution and agar disk diffusion methods specifically tailored for fastidious or rare bacteria.
Target Organisms: Provides testing conditions and interpretive criteria for organisms like Corynebacterium spp., Abiotrophia spp., Granulicatella spp., and Bacillus spp. (excluding B. anthracis).
Bioterrorism Preparedness: Includes specialized procedures for public health laboratories to handle potential bacterial agents of bioterrorism.
Advanced Identification Support: The latest editions include tables and taxonomic updates for organisms identified via MALDI-TOF mass spectrometry or sequencing.
Interpretive Criteria: Offers Minimal Inhibitory Concentration (MIC) and disk diffusion (DD) breakpoints that help clinicians select therapy for unusual pathogens. Access and Formats
The document is available for purchase and download through the following platforms:
The CLSI M45 document, titled Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, is a specialized guideline essential for clinical microbiology laboratories handling organisms that are not covered by the standard CLSI M100. Helpful Review & Key Highlights
Purpose: It bridges the gap for "fastidious" bacteria—those with complex nutritional requirements—and "infrequently isolated" organisms that often fail to grow in standard Mueller Hinton media.
Expanded Scope: The latest edition includes taxonomic updates and new tables for organisms likely identified through advanced technologies like MALDI-TOF mass spectrometry.
Bioterrorism Guidance: It is a critical resource for public health laboratories, providing protocols for testing bacteria potentially associated with bioterrorism. Technical Content:
Recommends both Broth Microdilution (BMD) and Disk Diffusion methods.
Provides specific interpretive criteria (breakpoints) for difficult-to-treat opportunistic pathogens like Pseudomonas species other than P. aeruginosa (POPA) and Achromobacter.
Offers guidance on when it is clinically relevant to perform susceptibility testing rather than relying on predictable patterns. Critical Limitations
Not for Commercial Devices: This guideline does not address commercial susceptibility testing systems; it focuses on reference methodologies.
Interpretive Stringency: Breakpoints in M45 are often based on less data (e.g., fewer PK/PD or clinical outcome studies) than those in M100, sometimes requiring extrapolation from related species. Access and Format
The document is available for purchase and download as a PDF through the official CLSI Shop. Educational previews of the M45-Ed3 table of contents are often available via the ANSI Webstore.
CLSI M45 provides essential guidelines for antimicrobial susceptibility testing of infrequently isolated, fastidious bacteria, filling a critical diagnostic gap left by broader standards. The document offers tailored interpretive criteria and quality control parameters for rare pathogens, enhancing clinical relevance and accuracy in resistance detection. Learn more at the official CLSI Shop.
The CLSI Document M45, titled Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, is a critical technical guideline for clinical, public health, and research laboratories. It serves as a specialized extension of the more common CLSI M100 performance standards, providing standardized testing protocols for bacteria that are not covered by standard methods due to their unique growth requirements or rarity. Core Purpose and Scope
The primary goal of CLSI M45 is to provide essential guidance for antimicrobial susceptibility testing (AST) when resistance is a concern and the organism's susceptibility cannot be predicted by its identity alone.
Target Organisms: It focuses on fastidious or infrequently isolated bacterial pathogens that are excluded from the broader M02, M07, and M100 documents.
Methodology: The document describes traditional broth microdilution and agar disk diffusion methods, including standardized procedures for performance, drug selection, and quality control (QC).
Application: These guidelines are intended to help laboratories determine relevant testing approaches for unusual organisms in their specific practice settings. Organisms Covered in M45
The guideline includes specific interpretive criteria and testing conditions for a wide range of diverse genera, including:
Fastidious Genera: Abiotrophia, Granulicatella, Aerococcus, Gemella, and the (H)ACEK group.
Environmental & Opportunistic Pathogens: Aeromonas spp., Bacillus spp. (excluding B. anthracis), Listeria monocytogenes, and Vibrio spp.
Emerging Pathogens: Newer editions have added tables for organisms like Pseudomonas species other than P. aeruginosa (POPA).
Public Health Concerns: Guidance for testing bacteria potentially associated with bioterrorism is also included. Current Edition and Correction Notices
The current edition is the 3rd Edition (M45-Ed3), originally published in August 2016.
Routine automated systems (VITEK, BD Phoenix, MicroScan) often lack validated databases for these unusual organisms. Without the CLSI M45 PDF, laboratories might resort to unvalidated methods, leading to:
M45 provides a legal and scientific shield for laboratorians: follow the M45 method, and your results are defensible. Deviate, and you bear the liability.
Many hospitals, university libraries, and reference labs subscribe to the CLSI eSubscription Service. This provides unlimited access to all current CLSI documents, including M45, via a portal. Users can download PDFs for internal use.
Searching the internet for a "free CLSI document M45 PDF" is risky. CLSI documents are copyrighted, and unauthorized copies found on file-sharing sites are often outdated, watermarked, or corrupted. Here is why securing the official PDF from CLSI or authorized distributors (like ANSI) is critical:
The CLSI M45 document, titled "Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria," provides critical guidelines for testing organisms that fall outside the more common species covered in the CLSI M100 standard. Key Features of CLSI M45
Standardized Methodology: It describes broth microdilution and agar disk diffusion methods specifically tailored for fastidious or rare bacteria.
Target Organisms: Provides testing conditions and interpretive criteria for organisms like Corynebacterium spp., Abiotrophia spp., Granulicatella spp., and Bacillus spp. (excluding B. anthracis).
Bioterrorism Preparedness: Includes specialized procedures for public health laboratories to handle potential bacterial agents of bioterrorism.
Advanced Identification Support: The latest editions include tables and taxonomic updates for organisms identified via MALDI-TOF mass spectrometry or sequencing.
Interpretive Criteria: Offers Minimal Inhibitory Concentration (MIC) and disk diffusion (DD) breakpoints that help clinicians select therapy for unusual pathogens. Access and Formats
The document is available for purchase and download through the following platforms:
The CLSI M45 document, titled Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, is a specialized guideline essential for clinical microbiology laboratories handling organisms that are not covered by the standard CLSI M100. Helpful Review & Key Highlights
Purpose: It bridges the gap for "fastidious" bacteria—those with complex nutritional requirements—and "infrequently isolated" organisms that often fail to grow in standard Mueller Hinton media. clsi document m45 pdf
Expanded Scope: The latest edition includes taxonomic updates and new tables for organisms likely identified through advanced technologies like MALDI-TOF mass spectrometry.
Bioterrorism Guidance: It is a critical resource for public health laboratories, providing protocols for testing bacteria potentially associated with bioterrorism. Technical Content:
Recommends both Broth Microdilution (BMD) and Disk Diffusion methods.
Provides specific interpretive criteria (breakpoints) for difficult-to-treat opportunistic pathogens like Pseudomonas species other than P. aeruginosa (POPA) and Achromobacter.
Offers guidance on when it is clinically relevant to perform susceptibility testing rather than relying on predictable patterns. Critical Limitations
Not for Commercial Devices: This guideline does not address commercial susceptibility testing systems; it focuses on reference methodologies.
Interpretive Stringency: Breakpoints in M45 are often based on less data (e.g., fewer PK/PD or clinical outcome studies) than those in M100, sometimes requiring extrapolation from related species. Access and Format
The document is available for purchase and download as a PDF through the official CLSI Shop. Educational previews of the M45-Ed3 table of contents are often available via the ANSI Webstore. The CLSI M45 document, titled "Methods for Antimicrobial
CLSI M45 provides essential guidelines for antimicrobial susceptibility testing of infrequently isolated, fastidious bacteria, filling a critical diagnostic gap left by broader standards. The document offers tailored interpretive criteria and quality control parameters for rare pathogens, enhancing clinical relevance and accuracy in resistance detection. Learn more at the official CLSI Shop.
The CLSI Document M45, titled Methods for Antimicrobial Dilution and Disk Susceptibility Testing of Infrequently Isolated or Fastidious Bacteria, is a critical technical guideline for clinical, public health, and research laboratories. It serves as a specialized extension of the more common CLSI M100 performance standards, providing standardized testing protocols for bacteria that are not covered by standard methods due to their unique growth requirements or rarity. Core Purpose and Scope
The primary goal of CLSI M45 is to provide essential guidance for antimicrobial susceptibility testing (AST) when resistance is a concern and the organism's susceptibility cannot be predicted by its identity alone.
Target Organisms: It focuses on fastidious or infrequently isolated bacterial pathogens that are excluded from the broader M02, M07, and M100 documents.
Methodology: The document describes traditional broth microdilution and agar disk diffusion methods, including standardized procedures for performance, drug selection, and quality control (QC).
Application: These guidelines are intended to help laboratories determine relevant testing approaches for unusual organisms in their specific practice settings. Organisms Covered in M45
The guideline includes specific interpretive criteria and testing conditions for a wide range of diverse genera, including:
Fastidious Genera: Abiotrophia, Granulicatella, Aerococcus, Gemella, and the (H)ACEK group. M45 provides a legal and scientific shield for
Environmental & Opportunistic Pathogens: Aeromonas spp., Bacillus spp. (excluding B. anthracis), Listeria monocytogenes, and Vibrio spp.
Emerging Pathogens: Newer editions have added tables for organisms like Pseudomonas species other than P. aeruginosa (POPA).
Public Health Concerns: Guidance for testing bacteria potentially associated with bioterrorism is also included. Current Edition and Correction Notices
The current edition is the 3rd Edition (M45-Ed3), originally published in August 2016.
Routine automated systems (VITEK, BD Phoenix, MicroScan) often lack validated databases for these unusual organisms. Without the CLSI M45 PDF, laboratories might resort to unvalidated methods, leading to:
M45 provides a legal and scientific shield for laboratorians: follow the M45 method, and your results are defensible. Deviate, and you bear the liability.
Many hospitals, university libraries, and reference labs subscribe to the CLSI eSubscription Service. This provides unlimited access to all current CLSI documents, including M45, via a portal. Users can download PDFs for internal use.
Searching the internet for a "free CLSI document M45 PDF" is risky. CLSI documents are copyrighted, and unauthorized copies found on file-sharing sites are often outdated, watermarked, or corrupted. Here is why securing the official PDF from CLSI or authorized distributors (like ANSI) is critical: